Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

Following Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks-down3.jpg" NAME"Following Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study" ALT"Following Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study"July 31, 2017By <A HREF"http://www.biospace.com/news_subject_all_results.aspx?CatagoryId40274"... Source: BioSpace

Continue ReadingFollowing Recent Death, InVivo Therapeutics Temporarily Halts Enrollment in INSPIRE Study

FDA Raises Big Safety Concerns With Johnson & Johnson's Arthritis Drug Sirukumab

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-johnson-johnson.jpg" NAME"FDA Raises Big Safety Concerns With Johnson & Johnson's Arthritis Drug Sirukumab" ALT"FDA Raises Big Safety Concerns With Johnson & Johnson's Arthritis Drug Sirukumab"July 31, 2017(Last Updated: July…

Continue ReadingFDA Raises Big Safety Concerns With Johnson & Johnson's Arthritis Drug Sirukumab

Bristol-Myers Squibb, Clovis Oncology Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x600-deal.jpg" NAME"Bristol-Myers, Clovis Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III" ALT"Bristol-Myers, Clovis Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III"July…

Continue ReadingBristol-Myers Squibb, Clovis Oncology Ink Pact to Marry Their PD-1/PARP Drugs in Phase II and III